Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
JD Sports, the UK sporting equipment retailer, is looking at the possibility of raising equity capital to help it through the next few months of Covid-19 lockdowns and to take advantage of investment opportunities in the future. -
CureVac, the German biotechnology company, has launched a $523m share sale to fund late stage clinical trials for its Covid-19 vaccine, and an expansion of its manufacturing capacity.
-
Chinese healthcare duo MicroPort CardioFlow Medtech Corp and Suzhou Basecare Medical Corp have kicked off their Hong Kong IPOs after a week of pre-marketing.
-
Fitch Ratings is poised to revise most of its CLO tranches outlooks from negative to stable, following a revision of its CLO coronavirus stress scenario, which is considered no longer representative of the near-term risks for CLOs.
-
Airline bonds have sold off in the secondary market as the industry faces another wave of new restrictions to combat Covid-19 variants.
-
Orient Overseas (International) has scooped up HK$932.5m ($120.3m) from a top-up placement, increasing the deal on strong anchor investor demand. Two other Hong Kong-listed companies, both from the healthcare sector, also turned to investors on Thursday.
